Polo-like kinase (PLK) 5, a new member of the PLK family, serves as a biomarker to indicate anabatic tumor burden and poor prognosis for resectable non-small cell lung cancer

OBJECTIVE: A review argues that polo-like kinase 5 (PLK5) may be linked to unfavorable prognosis in non-small cell lung cancer (NSCLC) patients, which contradicts the discoveries from The Human Protein Atlas database (derived from TCGA analysis). This study intended to comprehensively confirm the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kaichao, Shen, Shaohui, Dong, Liyuan, Fang, Qinmo, Hou, Xinlei, Shi, Xueliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856523/
https://www.ncbi.nlm.nih.gov/pubmed/36684318
http://dx.doi.org/10.3389/fsurg.2022.964044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856523/
https://www.ncbi.nlm.nih.gov/pubmed/36684318
http://dx.doi.org/10.3389/fsurg.2022.964044

Ejemplares similares